Shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) have shifted north recently, touching a new 52-week high. A recent bid put the stock price near $19.69. The stock has moved 14.13% over the last 5 sessions.Since the start of the calendar year, Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)’s stock has changed 81.34%. Over the last five trading sessions, the stock has moved 14.13%. For the past month, Concert Pharmaceuticals, Inc.’s stock has been 28.51%, 28.78% for the last quarter, 25.66% for the past six months and 89.83% for the past 52 weeks.
Based on current stock levels, Concert Pharmaceuticals, Inc. shares are trading 1.97% off of the 50-day high and 45.10% away from the 50-day low.
Earnings Per Share (EPS), the portion of a company’s profit distributed to each outstanding common share, is a useful indicator of a company’s profitability. EPS is typically considered to be the most important variable in determining a share’s price. Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)’s EPS growth this year is -310.10% and the trailing 12-month EPS is $3.78. Covering sell-side analysts are estimating company growth for next year to be -17.00%. On a consensus basis, analysts have given a recommendation of 1.80 on company shares.
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.